Mirabaud & Cie
BNTX icon

Mirabaud & Cie’s BioNTech BNTX Stock Holding History

Mirabaud & Cie’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$590K Hold
6,000
– – 0.23% 40
2026
Q2 		$558K Hold
6,000
– – 0.22% 38
2026
Q1 		$533K Hold
6,000
– – 0.22% 41
2025
Q4 		$571K Hold
6,000
– – 0.18% 48
2025
Q3 		$592K Hold
6,000
– – 0.19% 49
2025
Q2 		$639K Hold
6,000
– – 0.2% 48
2025
Q1 		$546K Hold
6,000
– – 0.19% 47
2024
Q4 		$684K Buy
+6,000
New +$685K 0.22% 47

Other funds holding BNTX

Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Slow Capital
Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Mirabaud & Cie's BNTX Position: Q3 2026 in Review

Mirabaud & Cie held its BioNTech (BNTX) position steady in Q3 2026 at 6,000 shares worth $590K. The position accounts for 0.23% of the portfolio, ranked #40.

Mirabaud & Cie first reported a position in BNTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $684K in Q4 2024. 71 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Mirabaud & Cie held 6,000 shares of BioNTech worth $590K as of Q3 2026.
  • Mirabaud & Cie left its BioNTech share count unchanged in Q3 2026.
  • BioNTech made up 0.23% of Mirabaud & Cie's portfolio in Q3 2026, its #40 holding.
  • Mirabaud & Cie first reported a position in BioNTech in Q4 2024 and has held it in 8 quarters since.
  • Mirabaud & Cie's BioNTech position peaked at $684K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Mirabaud & Cie's 13F filing for Q3 2026, filed 27 Oct 2026.